Vasodilator actions of HA1077 <i>in vitro</i> and <i>in vivo</i> putatively mediated by the inhibition of protein kinase
Toshio Asano(Asahi Chemical & Industry (Japan)), Hisashi Hidaka(Kitasato University), Ichiro Ikegaki, Yasuhíro Suzuki(Osaka City University), Takahito Suzuki(Hamamatsu Medical Center), Masahiko Tsuchiya(Asahi Chemical & Industry (Japan)), Shin’ichi Satoh(National Institute of Informatics), Masatoshi Shibuya(Tohoku University)
Cited by 131
Related Papers
Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.
|Journal of Biological Chemistry|1990|1.5k
KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
|Journal of Biological Chemistry|1990|625
N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.
|Proceedings of the National Academy of Sciences|1981|586
Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase.
|Journal of Biological Chemistry|1987|513
MAPKAP kinase‐2; a novel protein kinase activated by mitogen‐activated protein kinase.
|The EMBO Journal|1992|481